Cargando…
Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers
SIMPLE SUMMARY: Janus kinases (JAKs) are transmembrane receptors that pass signals from extracellular ligands to downstream. Increasing evidence has suggested that JAK family aberrations promote lymphoid cancer pathogenesis and progression through mediating gene expression via the JAK/STAT pathway o...
Autores principales: | Li, Boheng, Wan, Qin, Li, Zhubo, Chng, Wee-Joo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533975/ https://www.ncbi.nlm.nih.gov/pubmed/34680295 http://dx.doi.org/10.3390/cancers13205147 |
Ejemplares similares
-
EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications
por: Li, Boheng, et al.
Publicado: (2019) -
Janus Kinases in Leukemia
por: Raivola, Juuli, et al.
Publicado: (2021) -
The Janus kinases (Jaks)
por: Yamaoka, Kunihiro, et al.
Publicado: (2004) -
Janus kinase inhibitors: jackpot or potluck?
por: Pavithran, Keechilat, et al.
Publicado: (2012) -
Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation
por: Ortmann, Robert A, et al.
Publicado: (2000)